Articles, guides, and regulatory updates from our community.
New research explores antimicrobial peptide nanoparticles activated by near-infrared light to combat biofilm infections in diabetic wounds. Learn what the study found.
By Peptide Association Research Team
New research reveals how telehealth rules, NP authority, and compounding infrastructure create major geographic gaps in peptide-based sexual medicine access.
By Peptide Association Research Team
A 2026 clinical study suggests HMB supplementation may support immune response and intracellular amino acid synthesis in critically ill ICU patients.
By Peptide Association Research Team
New research explores how IL-15 and Thymosin α1 may reduce immune aging in hepatocellular carcinoma. Learn what the findings mean for future cancer therapy.
By Peptide Association Research Team
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by preserving mitochondrial function and reducing cell death in animal models.
By Peptide Association Research Team
A 2026 critical review examines peptide use in competitive and recreational sport, highlighting limited clinical evidence and emerging health risks. Read the findings.
By Peptide Association Research Team
A 2026 critical review reveals growing peptide use in sport and bodybuilding, with limited clinical evidence and poorly defined long-term safety risks.
By Peptide Association Research Team
New research explores GHK-Cu peptide microspheres for bone repair, suggesting dual osteogenic and angiogenic activity in laboratory models. Learn what this means.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may restore cancer-fighting immunity suppressed by chemotherapy. Learn what this 2026 study found and why it matters.
By Peptide Association Research Team
New research explores GHK-Cu peptide microspheres for bone repair. Learn what the study found about osteogenic and angiogenic activity in this evidence-based review.
By Peptide Association Research Team
New research suggests thymosin alpha-1 may help restore anti-tumor immunity after chemotherapy by activating dendritic cells. Learn what the study found.
By Peptide Association Research Team
A 2026 study found BPC-157 and hybrid analogs may inhibit acetylcholinesterase, a key enzyme in Alzheimer's disease. Learn what the research means.
By Peptide Association Research Team
New research links mitochondrial dysfunction and oxidative stress to gestational diabetes, placental problems, and offspring metabolic risk. Learn what the science shows.
By Peptide Association Research Team
A 2026 rat study suggests BPC 157 may reduce oxidative stress and muscle damage from ischemia-reperfusion injury. Learn what the research found.
By Peptide Association Research Team
New research on GHK-Cu peptide in aged mice suggests delivery route may shape cognitive and molecular outcomes. Learn what the findings mean for aging research.
By Peptide Association Research Team
New rat study suggests BPC 157 may reduce oxidative stress and tissue damage from ischemia-reperfusion injury. Read the findings and what they mean for research.
By Peptide Association Research Team
New research suggests SS-31 (Elamipretide) may modulate alpha-synuclein aggregation and restore mitochondrial function in Parkinson's-related models.
By Peptide Association Research Team
New research suggests the mitochondria-targeted peptide SS-31 may help protect cardiac function during doxorubicin chemotherapy. Learn what the study found.
By Peptide Association Research Team
New research suggests the peptide SS-31 (Elamipretide) may modulate α-synuclein aggregation and restore mitochondrial function linked to Parkinson's disease.
By Peptide Association Research Team
A 2026 review in Pharmaceutics examines BPC-157's development barriers, formulation challenges, and why human clinical data remains critically limited.
By Peptide Association Research Team
New rat study suggests BPC 157 may reduce oxidative stress and tissue damage from ischemia-reperfusion injury. Learn what the research shows and its limitations.
By Peptide Association Research Team
New research suggests the mitochondria-targeted peptide SS-31 may help protect cardiac function during doxorubicin chemotherapy by reducing oxidative stress.
By Peptide Association Research Team
New rat study suggests BPC 157 may reduce oxidative stress and tissue damage from ischemia-reperfusion injury. Learn what the research shows and its limitations.
By Peptide Association Research Team
A 2026 review in Pharmaceutics examines BPC-157's biopharmaceutical challenges, pharmacokinetic gaps, and the barriers standing between preclinical promise and human trials.
By Peptide Association Research Team
A 2026 rat study found BPC 157 may reduce oxidative stress and apoptosis in lower limb ischemia-reperfusion injury. Learn what the research suggests.
By Peptide Association Research Team
A 2026 review in Pharmaceutics examines why BPC-157 lacks approved formulations, validated dosing, and completed Phase II trials despite 30+ years of preclinical data.
By Peptide Association Research Team
A 2026 rat study suggests BPC 157 may protect against ischemia-reperfusion injury by reducing oxidative stress, inflammation, and cell death. Learn what the research shows.
By Peptide Association Research Team
A 2026 review in JBJS Reviews examines the evidence, safety, and antidoping implications of injectable peptides used in sports medicine and orthopaedics.
By Peptide Association Research Team
A 2026 structured review examines injectable peptides for musculoskeletal recovery. Learn what the evidence, safety data, and antidoping rules mean for athletes.
By Peptide Association Research Team
New research explores how mitochondria-targeted polydopamine nanoparticles modified with SS-31 peptide may protect the liver from ischemia-reperfusion injury.
By Peptide Association Research Team
A 2026 review study examines nanocarriers, host-directed therapies, and antimicrobial peptides as next-generation tuberculosis treatment strategies.
By Peptide Association Research Team
A 2026 study in Biogerontology suggests GHK-Cu may delay aging by supporting mitochondrial function and activating key longevity pathways. Learn what the research shows.
By Peptide Association Research Team
A 2026 study found BPC 157 may relax human arterial tissue via nitric oxide pathways. Learn what the research suggests and what patients should know.
By Peptide Association Research Team
A 2026 study suggests BPC 157 may relax human arterial tissue via nitric oxide signaling. Learn what the research found and what it means for vascular health.
By Peptide Association Research Team
A 2026 review study explores nanocarriers, host-directed therapies, and antimicrobial peptides as next-generation tuberculosis treatments. Learn what the research shows.
By Peptide Association Research Team
New research explores nanocarriers, antimicrobial peptides, and host-directed strategies as next-generation tuberculosis treatments. Learn what the science says.
By Peptide Association Research Team
New zebrafish research suggests GHK-Cu peptide may reduce inflammation and oxidative stress. Learn what the study found and what it means for future research.
By Peptide Association Research Team
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by protecting mitochondria and reducing cell death. Learn what the study found.
By Peptide Association Research Team
New research explores carbonless analogues of the GHK peptide using boron-nitrogen substitution. Learn what this computational study suggests about future peptide design.
By Peptide Association Research Team
New computational research explores carbonless analogues of GHK peptide, suggesting stronger copper binding and broader conformational flexibility. Learn what this means.
By Peptide Association Research Team
New research on carbonless amino acids reveals modified GHK peptides may have stronger metal binding properties. Study findings and clinical implications.
By Peptide Association Research Team